SAN JOSE, Calif., Sept. 28, 2018 /PRNewswire/ — ITUS Corporation (the “Company”) ITUS a biotechnology aggregation focused on application the body’s allowed arrangement to action cancer, today appear that on October 1, 2018, the Aggregation will acutely change its name to Anixa Biosciences, Inc. Effective at the alpha of trading on October 1, 2018, the Company’s shares will barter on the NASDAQ Capital Market beneath the new name, and the new b attribute will be “ANIX.” The Company’s website will be attainable at www.anixa.com.
Amit Kumar, the Company’s CEO stated, “We are focused on authoritative advances in the biotechnology field. We began in affection with development of the Cchek™ belvedere for aboriginal apprehension of blight and are accretion into blight ysis as we advance our CAR-T ysis for ovarian cancer. We accept the name Anixa Biosciences added accurately reflects this focus and acutely identifies us as biotech company. The ITUS name is added cogitating of our bequest operations.”
ITUS Corporation ITUS, a cancer-focused biotechnology company, is harnessing the body’s allowed arrangement in the action adjoin cancer. ITUS is developing both affection and ysis to ascertain blight early, back it is best curable, and to amusement those afflicted already diagnosed. It is developing the Cchek™ platform, a alternation of bargain non-invasive claret tests for the aboriginal apprehension of solid tumors, which is based on the body’s allowed acknowledgment to the attendance of a malignancy. It is additionally developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically architect a patient’s own allowed beef to action cancer. ITUS additionally always examines arising technologies in commutual or accompanying fields for added development and commercialization. Additional advice is accessible at www.ITUScorp.com.
Forward-Looking Statements: Statements that are not absolute actuality may be advised advanced statements aural the acceptation of the Private Securities Litigation Reform Act of 1995. Advanced statements are not statements of absolute facts, but rather reflect ITUS Corporation’s accepted expectations apropos approaching contest and results. We about use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “will” and agnate expressions to yze advanced statements. Such advanced statements, including those apropos our expectations, absorb risks, uncertainties and added factors, some of which are above our control, which may account our absolute results, achievement or achievements, or industry results, to be materially altered from any approaching results, performance, or achievements bidding or adumbrated by such advanced statements. These risks, uncertainties and factors include, but are not bound to, those factors set alternating in “Item 1A – Risk Factors” and added sections of our best contempo Annual Report on Form 10-K as able-bodied as in our Quarterly Reports on Form 10-Q and Accepted Reports on Form 8-K. We undertake no obligation to about amend or alter any advanced statements, whether as a aftereffect of new information, approaching contest or otherwise, except as appropriate by law. You are cautioned not to disproportionately await on such advanced statements back evaluating the advice presented in this columnist release.
View aboriginal agreeable to download multimedia:http://www.prnewswire.com/news-releases/itus-corporation-changing-company-name-to-anixa-biosciences-and-stock-ticker-sym-to-anix-300720731.html
SOURCE ITUS Corporation
Copyright (C) 2018 PR Newswire. All rights aloof
How I Successfuly Organized My Very Own S Corporation Form | S Corporation Form – s corporation form
| Welcome in order to our blog site, in this particular period I’m going to show you concerning s corporation form
. And now, here is the first picture: